Safety and Immunogenicity of Two 0.25 mL or 0.5 mL Doses of Two Different Influenza Vaccines in Healthy Children Aged 6 to <60 Months

Femme et Homme

| Pays :
| Organes :
| Spécialités :

Extrait

To evaluate the immunogenicity of two 0.25 mL IM doses of Fluad or Fluzone influenza vaccines in terms of post-vaccination geometric mean titers (GMTs), seroprotection rates and seroconversion rates, as measured by HI assay in subjects aged between 6 to <36 months, 36 to <60 months and 6 to <60 months. To evaluate the safety and tolerability of one and two 0.5 mL IM doses of Fluad or Fluzone influenza vaccines in unprimed healthy children aged between 6 to <36 months, 36 to <60 months and 6 to <60 months.

Critère d'inclusion

Influenza